stability guidance -draft
...of drug substance placed on stability should be representative of both the quality of the.....this guidance to mean a batch of drug substance or drug product manufactured at the scale.....compromise the quality, purity, or stability of the drug substance and the resulting drug..
http://www.fda.gov/cder/guidance/1707dft.pdf (score=100)
Guidance- Content & Format CMC for Vaccine & Related Product
...A list should be provided of all components in the drug product, including drug substance(s)and other ingredients, with.....This section should contain information on the stability of the drug substance and any in.....material at each holding step, as outlined in "Stability Testing of New Drug Substances..
http://www.fda.gov/cber/gdlns/cmcvacc.pdf (score=82)
MDI and DPI Drug Products
...establish a set of criteria to which a drug substance or drug product should conform using.....manufacturing, processing, packaging, controls, stability testing, or labeling operations.....of each facility involved in the manufacturing of the drug substance and excipients should..
http://www.fda.gov/cder/guidance/2180dft.pdf (score=61)
Chem Revs. of DMFs for DSIs
...Summarize the data showing that the container/closure system is compatible with the drug.....If a stability-indicating test is used which is different from the release test, this.....the bioavailability of the drug products made from the substance, including, for example,specifications relating to..
http://www.fda.gov/cder/mapp/5015-4.pdf (score=55)
WAIS Document Retrieval
...Such studies should normally be conducted on the drug product or drug substance containing the degradation.....Degradation products observed in stability studies conducted at recommended storage.....Safety studies should provide a comparison of results of safety testing of the drug product or drug substance..
http://www.fda.gov/cder/guidance/ichq3b.htm (score=48)
þÿ
...2 This guidance has been prepared by Drug Substance Technical Subcommittee of the Chemistry.....should explain the scientific reasons why a stability indicating procedure is not viable.....drug substance information to support NADAs and ANADAs can be formatted according to the CTD-Q..
http://www.fda.gov/cder/guidance/3969DFT.pdf (score=47)
þÿ
...2 This guidance has been prepared by Drug Substance Technical Subcommittee of the Chemistry.....should explain the scientific reasons why a stability indicating procedure is not viable.....drug substance information to support NADAs and ANADAs can be formatted according to the CTD-Q..
http://www.fda.gov/OHRMS/DOCKETS/98fr/2003d-0571-gdl0001.pdf (score=46)
FDA Concept Paper: Drug Products That Present Demonstrable Difficulties for...
...A vehicle that optimally delivers one drug substance may be inappropriate for delivery of a.....Factors such as drug stability in the vehicle, the specific product use, and the site of.....Skin temperature and moisture also influence the rate and extent of absorption of the drug..
http://www.fda.gov/cder/fdama/difconc.htm (score=45)
...Stability-indicating analytical methods should be developed to monitor the stability of the drug substance and.....The stability of a botanical drug substance or product generally should not be based entirely on the assay of the active.....These regulations require documentation of the drug substance, drug product, placebo, labeling..
http://www.fda.gov/cder/guidance/4592fnl.doc (score=45)
Substance
...individual batches of the drug substance used in animal and clinical testing, Drug Substance.....Stability.. The regulations require a full description of the stability of the drug.....the subsequent bioavailability and stability requirements of the final dosage form. II..
http://www.fda.gov/cder/guidance/drugsub.pdf (score=44)
Guidance for Industry: Monoclonal Antibodies Used as Reagents in Drug...
...2 The term drug substance, which is used throughout the text, is intended to include biological.....The mAb manufacturer should perform real-time stability studies of unconjugated and.....the potential impact on the biological safety, quality, and purity of the drug substance and/or..
http://www.fda.gov/cber/gdlns/mab032901.pdf (score=41)
...Drug Substance Stability A description of the storage conditions, study protocols and results supporting.....DRUG SUBSTANCE The drug substance is defined as the unformulated active substance which may be subsequently.....Stability data supporting the proposed shelf-life of the reconstituted drug product and..
http://www.fda.gov/cber/gdlns/cmcdna.txt (score=38)
ichq5c
...either drug substance or drug product should be based on long-term, real-time, real.....entity and the quantitative detection of degradation products should also be part of the.....size may be acceptable for drug substance stability testing provided that they are..constructed of the..
http://www.fda.gov/cder/guidance/ichq5c.pdf (score=37)
Guidance for Industry: FOR THE SUBMISSION OF CHEMISTRY, MANUFACTURING, AND...
...If the drug substance is intended to be sterile, evidence of container and closure integrity.....protocols and results supporting the stability of..the drug substance should be submitted.....devices, data on the stability of the drug product..in the delivery system should be..
http://www.fda.gov/cber/gdlns/cmcdna.pdf (score=36)
Content and Format of INDs for Phase 1 Studies of Drugs, Inclu
...Food and Drug Administration, Center for Drug Evaluation and Research,"IND Process and.....Information to support the stability of the drug..substance during the toxicologic studies.....Information to support the stability of the drug..substance during the toxicologic studies..
http://www.fda.gov/cder/guidance/clin2.pdf (score=36)
Guidance for Industry - On the Content and Format of Chemistry,...
...Allergenic Extracts, the biological drug substance is the sterile intermediate solution.....Draft Guidance for Industry on Testing Limits in Stability Protocols for Standardized.....This section should be completed for each biological drug substance identified as being present..
http://www.fda.gov/cber/gdlns/cmcaller.htm (score=34)
Issued: 04-23-1999 Guidance for Industry: Content and Format of Chemistry,
...For Allergenic Extracts, the biological drug substance is the sterile intermediate solution.....Draft Guidance for Industry on Testing Limits in Stability Protocols for Standardized.....produce the drug substance, including micronization and pulverization processes,blending..
http://www.fda.gov/cber/gdlns/cmcaller.pdf (score=34)
IND content and format for Phase 1 studies
...As clinical development of a drug product proceeds,sponsors should discuss the.....Information to support the stability of the drug..substance during the toxicologic studies.....Information to support the stability of the drug..substance during the toxicologic studies..
http://www.fda.gov/cder/guidance/phase1.pdf (score=34)
Definition of Identity Polymorphism
...Over the years FDA has approved many generic drug products based upon a drug substance with different physical form from.....For an enantiotropic system, the relative stability of a pair of solid forms inverts at.....Polymorphism is often characterized as the ability of a drug substance to exist as two or more..
http://www.fda.gov/ohrms/dockets/ac/02/briefing/3900B1_04_Polymorphism.htm (score=34)
...Containers of reduced size may be acceptable for drug substance stability testing provided that they are.....The quality of the batches of drug substance placed into the stability program should be representative of the quality of.....The drug substance entered into the stability program should be stored in containers that properly represent the actual..
http://www.fda.gov/cber/gdlns/ichq5c071096.txt (score=33)
Powered by viXML, providing custom search results
Las Vegas Injury Lawyer
